The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor
- PMID: 8393820
The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor
Abstract
Alteration of transcription factor function is becoming a common theme in molecular mechanisms of oncogenesis. A recent example of this trend is the isolation and characterization of the chromosome 11p13 Wilms tumor suppressor gene, WT1. The WT1 protein contains a DNA binding domain consisting of four zinc fingers of the Cys2-His2 class and a proline-glutamine rich region capable of regulating transcription. Deletions of the WT1 gene or point mutations which destroy the DNA binding activity of the protein are associated with the development of the pediatric nephroblastoma Wilms tumor and Denys-Drash syndrome. This article reviews the role of WT1 in normal kidney development processes, the known biochemical functions of the protein and the status of identifying target genes regulated by this potentially oncogenic transcription factor.
Similar articles
-
Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.Biochemistry. 1996 Sep 17;35(37):12070-6. doi: 10.1021/bi960758o. Biochemistry. 1996. PMID: 8810912
-
Wilms tumor and the WT1 gene.Exp Cell Res. 2001 Mar 10;264(1):74-99. doi: 10.1006/excr.2000.5131. Exp Cell Res. 2001. PMID: 11237525 Review.
-
Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.Cancer Res. 1993 Oct 15;53(20):4757-60. Cancer Res. 1993. PMID: 8402654
-
Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.Oncogene. 1995 Feb 2;10(3):415-22. Oncogene. 1995. PMID: 7845666
-
The role of Wilms' tumor genes.J Med Invest. 1999 Aug;46(3-4):130-40. J Med Invest. 1999. PMID: 10687307 Review.
Cited by
-
Cancer immunotherapy targeting WT1 protein.Int J Hematol. 2002 Aug;76(2):127-32. doi: 10.1007/BF02982574. Int J Hematol. 2002. PMID: 12215010 Review.
-
WT1 and glomerular diseases.Pediatr Nephrol. 2006 Nov;21(11):1653-60. doi: 10.1007/s00467-006-0208-1. Epub 2006 Aug 23. Pediatr Nephrol. 2006. PMID: 16927106 Review.
-
Case report: Denys- Drash syndrome.Eur Arch Paediatr Dent. 2007 Dec;8(4):219-23. doi: 10.1007/BF03262601. Eur Arch Paediatr Dent. 2007. PMID: 18076855
-
Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.Hum Mol Genet. 2014 Feb 1;23(3):796-809. doi: 10.1093/hmg/ddt462. Epub 2013 Sep 20. Hum Mol Genet. 2014. PMID: 24057671 Free PMC article.
-
Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.Am J Pathol. 1995 Feb;146(2):344-56. Am J Pathol. 1995. PMID: 7856747 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases